273 related articles for article (PubMed ID: 25881026)
1. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
Jagarlamudi KK; Hansson LO; Eriksson S
BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
[TBL] [Abstract][Full Text] [Related]
2. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
3. A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease.
Kumar JK; Aronsson AC; Pilko G; Zupan M; Kumer K; Fabjan T; Osredkar J; Eriksson S
Tumour Biol; 2016 Sep; 37(9):11937-11945. PubMed ID: 27079872
[TBL] [Abstract][Full Text] [Related]
4. Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
Jagarlamudi KK; L S; M Z; J O; P V; S E
PLoS One; 2022; 17(10):e0275444. PubMed ID: 36201558
[TBL] [Abstract][Full Text] [Related]
5. High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: implications for in vitro diagnostics.
Kiran Kumar J; Sharif H; Westberg S; von Euler H; Eriksson S
Vet J; 2013 Sep; 197(3):854-60. PubMed ID: 23831216
[TBL] [Abstract][Full Text] [Related]
6. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
[TBL] [Abstract][Full Text] [Related]
7. Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Bagegni N; Thomas S; Liu N; Luo J; Hoog J; Northfelt DW; Goetz MP; Forero A; Bergqvist M; Karen J; Neumüller M; Suh EM; Guo Z; Vij K; Sanati S; Ellis M; Ma CX
Breast Cancer Res; 2017 Nov; 19(1):123. PubMed ID: 29162134
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression.
Huang S; Lin J; Guo N; Zhang M; Yun X; Liu S; Zhou J; He E; Skog S
Asian Pac J Cancer Prev; 2011; 12(2):497-505. PubMed ID: 21545220
[TBL] [Abstract][Full Text] [Related]
9. AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays.
Kumar JK; Holmgren S; Levedahl KH; Höglund M; Venge P; Eriksson S
Biotechniques; 2020 Jun; 68(6):334-341. PubMed ID: 32336110
[TBL] [Abstract][Full Text] [Related]
10. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
Jagarlamudi KK; Shaw M
Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
[TBL] [Abstract][Full Text] [Related]
11. Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer.
Li HX; Lei DS; Wang XQ; Skog S; He Q
Oncol Rep; 2005 Jan; 13(1):145-9. PubMed ID: 15583816
[TBL] [Abstract][Full Text] [Related]
12. Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker.
Luo P; He E; Eriksson S; Zhou J; Hu G; Zhang J; Skog S
Eur J Cancer Prev; 2009 Jun; 18(3):220-4. PubMed ID: 19282758
[TBL] [Abstract][Full Text] [Related]
13. Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies.
Saellström S; Sharif H; Jagarlamudi KK; Rönnberg H; Wang L; Eriksson S
Res Vet Sci; 2022 Jul; 145():213-221. PubMed ID: 35245727
[TBL] [Abstract][Full Text] [Related]
14. Thymidine kinase 1: a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients.
Zhang J; Jia Q; Zou S; Zhang P; Zhang X; Skog S; Luo P; Zhang W; He Q
Oncol Rep; 2006 Feb; 15(2):455-61. PubMed ID: 16391869
[TBL] [Abstract][Full Text] [Related]
15. A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.
Sharif H; von Euler H; Westberg S; He E; Wang L; Eriksson S
Vet J; 2012 Oct; 194(1):40-7. PubMed ID: 22516918
[TBL] [Abstract][Full Text] [Related]
16. Elevation of serum thymidine kinase 1 in a bacterial infection: canine pyometra.
Sharif H; Hagman R; Wang L; Eriksson S
Theriogenology; 2013 Jan; 79(1):17-23. PubMed ID: 23102844
[TBL] [Abstract][Full Text] [Related]
17. Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer.
Larsson AM; Bendahl PO; Aaltonen K; Jansson S; Forsare C; Bergqvist M; Jørgensen CLT; Rydén L
Sci Rep; 2020 Mar; 10(1):4484. PubMed ID: 32161278
[TBL] [Abstract][Full Text] [Related]
18. Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humans.
Hanan S; Jagarlamudi KK; Liya W; Ellen H; Staffan E
BMC Biochem; 2012 Jun; 13():12. PubMed ID: 22741536
[TBL] [Abstract][Full Text] [Related]
19. Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay.
Chen ZH; Huang SQ; Wang Y; Yang AZ; Wen J; Xu XH; Chen Y; Chen QB; Wang YH; He E; Zhou J; Skog S
Sensors (Basel); 2011; 11(12):11064-80. PubMed ID: 22247653
[TBL] [Abstract][Full Text] [Related]
20. Concentration of thymidine kinase 1 in serum (S-TK1) is a more sensitive proliferation marker in human solid tumors than its activity.
He Q; Zhang P; Zou L; Li H; Wang X; Zhou S; Fornander T; Skog S
Oncol Rep; 2005 Oct; 14(4):1013-9. PubMed ID: 16142366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
